LTUS

Lotus Pharmaceuticals, Inc. LTUS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode LTUS BFYW OHCS AWWI IGSC IKTO ALDA VNTA AMLH CDSG
6M -41.04 % 100.00 % -96.15 % 0.00 % 0.00 % -50.00 % -96.82 % 216.13 % 0.00 % 71.43 %
YTD -38.33 % -56.52 % -98.00 % 0.00 % -36.00 % -33.33 % -96.82 % 887.50 % 0.00 % 81.82 %
1Y -2.63 % -85.71 % -98.11 % 0.00 % -52.94 % -71.43 % -96.82 % -50.63 % -50.00 % 87.50 %
3Y -53.75 % -99.16 % -99.87 % -83.70 % -77.90 % -50.00 % -98.16 % -93.63 % -84.62 % -91.18 %
5Y -63.00 % -94.29 % -98.40 % -88.24 % 100.63 % -71.43 % -90.00 % -96.65 % 0.00 % -62.50 %
10Y -72.39 % -99.46 % -99.91 % -71.15 % -99.99 % 100.00 % -94.17 % -78.06 % -98.97 % -25.00 %
From the beginning -99.54 % -98.70 % -99.93 % -98.93 % -99.99 % -100.00 % -93.14 % -99.96 % -99.98 % -99.86 %

Dividend

Optimus Healthcare Services, Inc.